We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Bc9.0
BCAAs Research
Probably helpsHigh safety
48 peer-reviewed studies
What the evidence says
Probably helps
BCAAs helped in about half (7/13) of the studies that measured an effect — promising, but not unanimous.
Most evidence is from high-quality meta-analyses and randomised trials published 2006–2026 with a typical study size of 96 participants.
Based on 48 studies · 14 meta-analyses · 13 RCTs · 23,203 total participants
Confidence
High
What the studies found
7helped4unclear2didn't help· 35 more without graded effect data
By outcome
Therapeutic & clinical
Likely helps16 studies
Lean body mass & muscle growthMuscle protein synthesis support · Immediate to 2 hours
Probably helps13 studies
RecoveryReduced muscle soreness · 24-48 hours
Mostly mechanism / observational10 studies
Glucose & metabolic
Mostly mechanism / observational7 studies
Heart & blood pressure
Mostly mechanism / observational5 studies
Muscle strength & powerMuscle protein synthesis support · Immediate to 2 hours
Mostly mechanism / observational4 studies
Endurance & exercise performanceReduced mental fatigue during exercise · During exercise · Modest reduction in central fatigue during endurance work · Ongoing
Mostly mechanism / observational4 studies
Energy & fatigueReduces central fatigue during prolonged exercise · During exercise
Mostly mechanism / observational3 studies
Liver health
Too few graded studies1 study
Safety profile
Too few graded studies1 study
By the numbers
Pulled from 31 studies with measurable effects
Likely real effects
60%
across studies
People studied
23k
typical study: 96 people
Strongest designs
27
14 pooled, 13 randomised
Showed benefit
54%
7/13 studies
How long studies ran
1–3 months
1
3+ months
2
Populations Studied
General population5
Exercise participants2
Cirrhotic patients1
Old patients with sarcopenia1
Active research area
40 studies in the last 5 years · Latest meta-analysis: 2025
200620162026
1Event-free survival in cirrhotic patientsMeta-AnalysisCited 21×n=2,308 · very large study2023
Prophylactic BCAA supplementation appears safe and might improve survival in cirrhotic patients.
van Dijk AM et al. · European journal of clinical investigation (2023)
Large benefit
← WorseNo effectBetter →
Likely real
According to meta-analyses, long-term (at least 6 months) BCAA supplementation in cirrhotic patients significantly improved event-free survival (p = .008; RR .61 95% CI .42-.88) and tended to improve overall survival (p = .05; RR .58 95% CI .34-1.00).
Prophylactic BCAA supplementation appears safe and might improve survival in cirrhotic patients.
2Sarcopenia treatment and mitochondrial functionSystematic ReviewCited 27×n=1,337 · large study2023
PROSPERO CRD42022332288.
Cochet C et al. · Nutrients (2023)
Mitochondrial function was significantly improved by the administration of BCAA alone (1 RCT) or in association with vitamin D (1 RCT).
BCAA alone (2 RCTs) or PUFA (1 RCT) were not effective in improving muscle health.
In conclusion, BCAA in association with vitamin D may be useful in the treatment of sarcopenia and boost mitochondrial bioenergetic and redox activity.
4Cardiovascular disease riskMeta-AnalysisCited 30×n=2,806 · very large study2022
Evidence suggests that elevated concentrations of circulating Isoleucine were associated with increased risks of CVD, independent of traditional risk factors.
Wang Y et al. · Atherosclerosis (2022)
Noticeable harm
← WorseNo effectBetter →
Nine prospective studies were meta-analyzed and highlighted a 10% higher risk of CVD per study-specific SD difference for Isoleucine (pooled relative risk 1.10 [1.03-1.18]; I2 = 63.5%).
Evidence suggests that elevated concentrations of circulating Isoleucine were associated with increased risks of CVD, independent of traditional risk factors.
5Type 2 diabetes riskMeta-AnalysisCited 732×n=8,000 · very large study2016
In studies using high-throughput metabolomics, several blood amino acids appear to be consistently associated with the risk of developing type 2 diabetes.
Guasch-Ferré M et al. · Diabetes care (2016)
Noticeable benefit
← WorseNo effectBetter →
Glycine and glutamine were inversely associated with type 2 diabetes risk (0.89 [0.81-0.96] and 0.85 [0.82-0.89], respectively; both I(2) = 0.0%).
In studies using high-throughput metabolomics, several blood amino acids appear to be consistently associated with the risk of developing type 2 diabetes.
6Peripheral fatigue and hormone responsesMeta-Analysisn=146 · medium study2024
The advantages of BCAA administration relate to a reduction in cortisol concentration after 2h and ameliorated muscle function because of a probable attenuation of fatigue substances immediately after exercise.
Pourgharib Shahi MH et al. · Minerva endocrinology (2024)
The advantages of BCAA administration relate to a reduction in cortisol concentration after 2h and ameliorated muscle function because of a probable attenuation of fatigue substances immediately after exercise.
7Seizure activitySystematic ReviewCited 16×n=2,045 · very large study2019
The contradictory effects of BCAAs on seizure activity likely reflect differences in the complex mechanisms that underlie seizure disorders.
Gruenbaum SE et al. · CNS drugs (2019)
The contradictory effects of BCAAs on seizure activity likely reflect differences in the complex mechanisms that underlie seizure disorders.
Some of these mechanisms are likely mediated by BCAA's effects on glucose, glutamate, glutamine, and ammonia metabolism, activation of the mechanistic target of rapamycin signaling pathway, and their effects on aromatic amino acid transport and neurotransmitter synthesis.
We propose that a better understanding of mechanisms by which BCAAs affect seizures and neuronal viability is needed to advance the field of BCAA supplementation in epilepsy.
8Hepatic encephalopathyMeta-AnalysisCited 165×n=827 · large study2017
In this updated review, we included five additional trials.
Gluud LL et al. · The Cochrane database of systematic reviews (2017)
Large benefit
← WorseNo effectBetter →
In a random-effects meta-analysis of mortality, we found no difference between BCAA and controls (risk ratio (RR) 0.88, 95% confidence interval (CI) 0.69 to 1.11; 760 participants; 15 trials; moderate quality of evidence).
BCAA had a beneficial effect on hepatic encephalopathy (RR 0.73, 95% CI 0.61 to 0.88; 827 participants; 16 trials; high quality of evidence).
We found no small-study effects and confirmed the beneficial effect of BCAA in a sensitivity analysis that only included trials with a low risk of bias (RR 0.71, 95% CI 0.52 to 0.96).
Further studies are warranted to confirm the effects of the supplements on football players, to identify the appropriate dosage of the supplements and also to determine their mechanism of action.
Allahyari P et al. · Journal of basic and clinical physiology and pharmacology (2025)
B vitamins reduce the level of blood lactate in the recovery periods.
Vitamin E and vitamin C may improve performance by decreasing oxidative stress and increasing the antioxidant capacity and oxygen delivery to exercising skeletal muscles.
10Muscle performance recoveryMeta-AnalysisCited 22×n=479 · medium study2021
BCAA does not accelerate recovery for muscle performance.
Doma K et al. · Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme (2021)
No clear effect
← WorseNo effectBetter →
Borderline
In total, 25 studies were included, consisting of 479 participants (age 24.3 ± 8.3 years, height 1.73 ± 0.06 m, body mass 70.8 ± 9.5 kg, females 26.3%).
However, no significant differences were identified between the BCAA and placebo conditions for muscle performance at 24 or 48 hours post-exercise (SMD = 0.08 ≤ d ≤ 0.21; p > 0.05).
However, the potential benefits of BCAA for muscle performance recovery is questionable and warrants further investigation to determine the practicality of BCAA for ameliorating muscle damage symptoms in diverse populations.
11Cancer risk and mortalityMeta-AnalysisCited 1×2024
Our findings showed no significant association between dietary BCAAs and its components with BC and digestive cancers, BC and digestive cancers mortality, and all-cause mortality.
Tabesh M et al. · Nutrition and cancer (2024)
No clear effect
← WorseNo effectBetter →
The present study showed no statistically significant association between dietary BCAAs and its components with BC and digestive cancers (RRBCAA: 0.87, 95% CI: 0.68-1.10, RRLeucine: 0.74, 95% CI: 0.52-1.04, RRIsoleucine: 0.98, 95% CI: 0.93-1.04, RRValine: 0.76, 95% CI: 0.55-1.05).
Eight articles (six studies on breast cancer (BC) and digestive cancers risk, and three studies on both BC and digestive cancers mortality, and all-cause mortality) were included.
We extracted the reported hazard ratio (HR) with 95% confidence interval (CI) and odds ratio (OR) with 95%CI in cohorts and case-control studies, respectively, and computed the log HR or OR and its standard error.
Then, we used the random-effects model with inverse variance weighting method for the present meta-analysis, to calculate the pooled effect size.
The pooled results indicated that there was no significant association between serum BCAAs (RR: 1.17; 95% CI 0.85-1.60), isoleucine (RR: 1.41; 95%CI 0.92-2.17), leucine (RR: 1.13; 95% CI 0.94-1.36), and valine (RR: 1.02; 95%CI 0.86-1.22) and all-cause mortality.
13Athletic performance and body compositionSystematic ReviewCited 41×n=24 · very small study2022
Moreover, most of the studies did not report the total protein intake across the day and, consequently, the benefits of BCAAs should be interpreted with caution.
Martinho DV et al. · Nutrients (2022)
Although BCAAs tended to activate anabolic signals, the benefits on performance and body composition were negligible.
On the other hand, studies that included resistance participants showed that BCAAs attenuated muscle soreness after exercise, while in endurance sports the findings were inconsistent.
The protocols of BCAA supplements differed considerably between studies.
14Body composition in liver cirrhosisSystematic ReviewCited 31×n=22 · very small study2022
While body composition in cirrhosis may improve with diet and exercise prescription, suitably powered RCTs of combined interventions, targeting overweight/obese populations, and using guideline-recommended body composition measures are needed to clarify if sarcopenia/sarcopenic obesity is modifiable in patients with cirrhosis.
Johnston HE et al. · Nutrients (2022)
When guideline-recommended measures of body composition were used, the largest improvements occurred with combined diet and exercise interventions.
These mostly employed high protein diets with aerobic and or resistance exercises for at least 8 weeks.
Benefits were also observed with supplementary branched-chain amino acids.
According to the GRADE methodology, no positive recommendation for these nutritional supplements may be expressed.
Braha A et al. · Medicina (Kaunas, Lithuania) (2022)
Background and Objectives: The prevalence of cachexia has increased across all of the cancer types and accounts for up to 20% of cancer-related deaths.
Conclusions: Although clinical trials relating to large numbers of nutritional supplements present promising data, many trials provided negative results.
Further studies investigating the underlying mechanisms of action of these nutritional supplements in cancer cachexia are needed.
Supplementation with BCAA seems to improve significant prognostic factors for patients with cirrhosis, with potential positive impact in mortality.
Konstantis G et al. · Clinical nutrition (Edinburgh, Scotland) (2022)
Noticeable benefit
← WorseNo effectBetter →
Relative to other interventions BCAAs showed beneficial effect regarding muscle mass (SMD 0.21, 95% CI 0.01 to 0.4, I2 0%), but no effect regarding fat mass.
Supplementation with BCAA seems to improve significant prognostic factors for patients with cirrhosis, with potential positive impact in mortality.
Heterogeneity of study findings attributed to many factors limit overall conclusion and results require further assessment.
18Systematic ReviewCited 37×n=11 · very small study2018
Although our review demonstrates an overall positive association between BCAAs and TBI outcome, the evidence of the efficacy of supplementation has been limited to severe TBI.
Sharma B et al. · The Journal of head trauma rehabilitation (2018)
Although our review demonstrates an overall positive association between BCAAs and TBI outcome, the evidence of the efficacy of supplementation has been limited to severe TBI.
To date, there is insufficient evidence to determine the benefits of BCAAs in mild TBI.
Given the high frequency of mild TBI and the promise of BCAAs as an intervention in severe TBI, future research should examine the effects of BCAAs in milder brain injury.
20Handgrip strength and clinical outcomes in cirrhosisMeta-Analysisn=3,128 · very large study2025
Oral nutritional therapy is associated with reduced risk of decompensation, overt hepatic encephalopathy, hospitalization, and short-term mortality in cirrhosis.
Ahmed HM et al. · Clinical nutrition ESPEN (2025)
Noticeable benefit
← WorseNo effectBetter →
Handgrip strength improved significantly (MD 2.41 kg; 95 % CI 0.58-4.24; I2 87 %), and LFI showed borderline improvement (MD -0.35; 95 % CI -0.70 to -0.0005; I2 84.4 %).
Oral nutritional therapy is associated with reduced risk of decompensation, overt hepatic encephalopathy, hospitalization, and short-term mortality in cirrhosis.
While improvements in sarcopenia and frailty were observed, high heterogeneity limits firm conclusions.